# Matthew J. During

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/matthew-j-during/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,591 |
| Field | Neuroscience and Neuropharmacology Research |
| h-index | 74 |
| i10-index | 169 |
| Last Known Institution | Ovid Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5109218920 |
| Works | 217 |

## Researcher papers

- [Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial](https://scholariq.org/papers/safety-and-tolerability-of-gene-therapy-with-an-adeno-associated-virus-aav-borne/)
- [AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial](https://scholariq.org/papers/aav2-gad-gene-therapy-for-advanced-parkinson-s-disease-a-double-blind-sham/)

## Researcher topics

- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Virus-based gene therapy research](https://scholariq.org/topics/virus-based-gene-therapy-research-2/)
- [RNA Interference and Gene Delivery](https://scholariq.org/topics/rna-interference-and-gene-delivery/)
- [Nerve injury and regeneration](https://scholariq.org/topics/nerve-injury-and-regeneration/)
- [Neurotransmitter Receptor Influence on Behavior](https://scholariq.org/topics/neurotransmitter-receptor-influence-on-behavior/)

## Researcher university

- [Ovid Therapeutics (United States)](https://scholariq.org/institutions/ovid-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.